BTI-322 For Acute Rejection After Renal Transplantation

By Mourad M.   Besse T.   Malaise J.   Baldi A.   Latinne D.   Bazin H.   Pirson Y.   Hope J.   Squifflet J.-P.  

Transplantation Proceedings, Vol. 29, Iss. 5, 1997-08 ,pp. : 2353-2353

Elsevier

Access to resources Recommend Favorite

BTI-322 for Induction Therapy After Renal Transplantation: A Randomized Study

By Squifflet J.-P.   Besse T.   Malaise J.   Mourad M.   Delcorde C.   Hope J.A.   Pirson Y.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 317-319

Elsevier

Access to resources Recommend Favorite

Tacrolimus Rescue Therapy in Late Rejection After Renal Transplantation: Outcome After 18 Months

By Budde K.   Fritsche L.   Smettan S.   Schonberger B.   Loening S.A.   Mai I.   Bauer S.   Waiser J.   Neumayer H.-H.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1238-1239

Elsevier

Access to resources Recommend Favorite

Beneficial effects of 15-deoxyspergualin on late acute rejection occurring more than three months after renal transplantation

By Amada N.   Okazaki H.   Sato T.   Miura S.   Ohashi Y.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2246-2247

Elsevier

Access to resources Recommend Favorite

Placebo-Controlled Study of a Humanized Anti-TAC Monoclonal Antibody in Dual Therapy for Prevention of Acute Rejection After Renal Transplantation

By Charpentier B.   Thervet E.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1331-1332

Elsevier

Access to resources Recommend Favorite